Tuesday, May 21, 2013 Last update: 12:34 PM
Company Tech News as it Breaks
Trade Events
Retrophin, Inc.
News articles for Retrophin, Inc.:
Wednesday, May 8, 2013
- Retrophin Names Marc L. Panoff as Chief Financial OfficerRetrophin, Inc. (OTCQB: RTRX) today announced that it has named Marc L. Panoff, CPA, MBA as Chief Financial Officer and Chief Accounting Officer, effective May 20. Retrophin is ... read more
Monday, April 8, 2013
- Retrophin Sponsors Seventh International NBIA Disorders Association Family ConferenceRetrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the discovery and development of orphan drugs for the treatment of rare and life-threatening diseases for which there are ... read more
Monday, March 11, 2013
- Retrophin Announces Positive Results from Preclinical Studies of RE-024 for PKANRetrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the discovery and development of orphan drugs for the treatment of rare and life-threatening diseases for which there are ... read more
Friday, March 8, 2013
- Retrophin to Present at 25th Annual ROTH ConferenceRetrophin, Inc. (OTCQB: RTRX), a biotechnology company focused on the discovery and development of orphan drugs for the treatment of rare and life-threatening diseases for which there are ... read more
Tuesday, February 12, 2013
- Retrophin Raises $10.0 Million in Private PlacementDesert Gateway (OTCPK: RTRX), the parent company of Retrophin, Inc., a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced it has ... read more
Tuesday, December 18, 2012
- Retrophin Completes Reverse Merger With Desert Gateway, Inc.Retrophin, Inc., a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced the successful completion of its merger with Desert Gateway, ... read more